Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Doreen Garabedian"'
Autor:
Kening Wang, David M. Koelle, Sally Hunsberger, Siu Ping Turk, Ronald L Hornung, Aiying Chen, Kerry J. Laing, Chetan Seshadri, Lesia K. Dropulic, Sanjay Phogat, Lee-Jah Chang, Malisa T. Smith, Jeffrey I. Cohen, Makinna C Oestreich, Doreen Garabedian, Nancy Ann Hosken, Keith Lumbard, Harlan L Pietz
Publikováno v:
J Infect Dis
Background Herpes simplex virus 2 (HSV2) causes genital herpes in >400 million persons worldwide. Methods We conducted a randomized, double-blinded, placebo-controlled trial of a replication-defective HSV2 vaccine, HSV529. Twenty adults were enrolled
Autor:
Sally Hunsberger, Mir A. Ali, John Shon, Hanh Nguyen, Keith Lumbard, Jaymie R Sawyer, Joel Bozekowski, Kening Wang, Jack Reifert, Harlan L Pietz, Doreen Garabedian, Winston A. Haynes, Lesia K. Dropulic, Joshua S Vogel, Kennichi C. Dowdell, Patrick S. Daugherty, Sinthujan Jegaskanda, Makinna C Oestreich, Jeffrey I. Cohen
Publikováno v:
J Infect Dis
Previous herpes simplex virus type 2 (HSV-2) vaccines have not prevented genital herpes. Concerns have been raised about the choice of antigen, the type of antibody induced by the vaccine, and whether antibody is present in the genital tract where in
Autor:
Doreen Garabedian, Kennichi C. Dowdell, Evan Shereck, Geoffrey T. Hart, Julie E. Niemela, Hye Sun Kuehn, Qingxue Li, Lesia K. Dropulic, Laura Schulz, Matthew K. Howe, Tatyana Feldman, Eric O. Long, Jennifer Stoddard, Gulbu Uzel, Jeffrey I. Cohen, Hua Su, Sergio D. Rosenzweig, Kelly Liepshutz, Amy P. Hsu
Publikováno v:
J Infect Dis
Background Chronic active Epstein-Barr virus (CAEBV) presents with high levels of viral genomes in blood and tissue infiltration with Epstein-Barr virus (EBV)–positive lymphocytes. The pathogenesis of CAEBV is poorly understood. Methods We evaluate
Autor:
Keith Lumbard, Sally Hunsberger, Harlan Pietz, Kerry J. Laing, Lesia K. Dropulic, Aiying Chen, Doreen Garabedian, Sanjay Phogat, Kening Wang, Kennichi C. Dowdell, David M. Koelle, Aaron Azose, Lee-Jah Chang, Hanh T. Nguyen, Jeffrey I. Cohen, Sinthujan Jegaskanda, Makinna Oestreich
Publikováno v:
Open Forum Infectious Diseases
Background We conducted a phase 1, randomized, double-blind, placebo-controlled trial of a replication-defective HSV-2 vaccine, HSV529 (deleted for UL5 and UL29), in 60 healthy adults aged 18 to 40 years. Methods Subjects were enrolled in groups of 2